Detalles de la búsqueda
1.
Site-directed biochemical analyses reveal that the switchable C-terminus of Rpc31 contributes to RNA polymerase III transcription initiation.
Nucleic Acids Res
; 51(9): 4223-4236, 2023 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36484109
2.
Mutational and biophysical analyses reveal a TFIIIC binding region in the TFIIF-related Rpc53 subunit of RNA polymerase III.
J Biol Chem
; 299(7): 104859, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37230389
3.
Glucose-lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification.
Diabet Med
; 41(2): e15200, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37578188
4.
HbA1c trajectories over 3 years in people with type 2 diabetes starting second-line glucose-lowering therapy: The prospective global DISCOVER study.
Diabetes Obes Metab
; 25(7): 1890-1899, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906837
5.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Diabetes Obes Metab
; 25(1): 46-55, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111434
6.
Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain.
BMC Health Serv Res
; 23(1): 1340, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041087
7.
PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport.
J Biol Chem
; 296: 100052, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33168624
8.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Am Heart J
; 243: 232-239, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34666013
9.
Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER.
BMC Endocr Disord
; 22(1): 111, 2022 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35473607
10.
Healthcare resource utilization and costs among patients with heart failure with preserved, mildly reduced, and reduced ejection fraction in Spain.
BMC Health Serv Res
; 22(1): 1241, 2022 Oct 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209120
11.
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Cardiovasc Diabetol
; 20(1): 159, 2021 07 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34332558
12.
What are the factors associated with long-term glycaemic control in patients with type 2 diabetes and elevated glycated haemoglobin (≥7.0%) at initiation of second-line therapy? Results from the DISCOVER study.
Diabetes Obes Metab
; 23(10): 2336-2343, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34212481
13.
Associations between second-line glucose-lowering combination therapies with metformin and HbA1c, body weight, quality of life, hypoglycaemic events and glucose-lowering treatment intensification: The DISCOVER study.
Diabetes Obes Metab
; 23(8): 1823-1833, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852202
14.
Association of sodium-glucose cotransporter-2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD-REAL 2 study.
Diabetes Obes Metab
; 23(6): 1431-1435, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606906
15.
Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(8): 1956-1960, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33852196
16.
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
Diabetes Obes Metab
; 23(1): 39-48, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32845558
17.
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus.
Am J Nephrol
; 51(1): 74-82, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31812955
18.
Glycaemic control in patients with type 2 diabetes initiating second-line therapy: Results from the global DISCOVER study programme.
Diabetes Obes Metab
; 22(1): 66-78, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468637
19.
Deriving a sub-nanomolar affinity peptide from TAP to enable smFRET analysis of RNA polymerase II complexes.
Methods
; 159-160: 59-69, 2019 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30742995
20.
Accelerated corneal endothelial cell loss in two patients with granulomatosis with polyangiitis following phacoemulsification.
BMC Ophthalmol
; 20(1): 480, 2020 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33287743